A detailed history of Roman Butler Fullerton & CO transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Roman Butler Fullerton & CO holds 107,626 shares of ADMA stock, worth $2.1 Million. This represents 0.64% of its overall portfolio holdings.

Number of Shares
107,626
Previous 31,505 241.62%
Holding current value
$2.1 Million
Previous $352,000 511.08%
% of portfolio
0.64%
Previous 0.12%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$11.21 - $20.03 $853,316 - $1.52 Million
76,121 Added 241.62%
107,626 $2.15 Million
Q2 2024

Jul 15, 2024

BUY
$5.98 - $11.18 $188,399 - $352,225
31,505 New
31,505 $352,000

Others Institutions Holding ADMA

About ADMA BIOLOGICS, INC.


  • Ticker ADMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 196,356,992
  • Market Cap $3.84B
  • Description
  • ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...
More about ADMA
Track This Portfolio

Track Roman Butler Fullerton & CO Portfolio

Follow Roman Butler Fullerton & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Roman Butler Fullerton & CO, based on Form 13F filings with the SEC.

News

Stay updated on Roman Butler Fullerton & CO with notifications on news.